SAB Biotherapeutics, Inc. (SABS): 3 filed Jan 7, 2026

Form type
3
Filing date
Jan 7, 2026
Accession number
0001193125-26-006407
Filer
SAB Biotherapeutics, Inc. (CIK 1833214)